Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR™ Peptide Enhanced Bone Graft in ...
The FDA has approved a biologic bone graft for use in the cervical spine. The i-Factor peptide enhanced bone graft from Cerapedics Inc. (Westminster, Colo.), a private orthobiologics company, was ...
Spinal fusion has been the gold standard for treating degenerative disc disease, but technology advances are either challenging it or transforming the procedure with the goal to improve how spinal ...
Each year, about 2.2 million bone-grafting procedures are performed worldwide, the gold standard of care being autografting, which uses the patient's own bone for tooth implantation and to repair and ...
SeaSpine Holdings Corporation SPNE announced the complete commercial launch of its Admiral ACP System for anterior cervical discectomy and fusion (ACDF) procedures. Admiral ACP features the next ...
A glue-gun-like device that can be used to print biodegradable bone grafts directly into fractures could revolutionize orthopedic surgery, offering personalized implants that speed healing and cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results